FDA approves updated Covid-19 vaccines for dominant XFG variant

The FDA has approved updated Covid-19 vaccines from Moderna, Novavax-Sanofi, and Pfizer-BioNTech, clearing the way for manufacturers to start distributing doses nationwide. The new formulations are designed to target the currently dominant XFG variant, following recommendations from an FDA advisory panel. While shipments to pharmacies and medical offices can now begin, uncertainty persists about how insurance plans will cover the updated shots. Confusion over reimbursement may delay some recipients from receiving the latest vaccines despite their availability.

Decision allows manufacturers to begin shipping doses, but confusion remains about insurance coverageThe US Food and Drug Administration approved updated Covid-19 vaccines on Thursday, allowing manufacturers to begin shipping doses to pharmacies and doctors’ offices across the country.The FDA approved Moderna, Novavax-Sanofi and Pfizer-BioNTech’s updated Covid vaccines, the companies ⁠said on Thursday, ⁠after ​an advisory panel recommended that the shots should target ⁠the dominant XFG variant. Continue reading...